Clinical Trial Update: Irbesartan-Hydrochlorothiazide Phase IV Study: Treatment of Hypertension in Chinese Population [Phase 4]

View source ↗

Summary

A Phase IV trial of the irbesartan/hydrochlorothiazide combination for hypertension in Chinese patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Irbesartan/Hydrochlorothiazide (irbesartan/hydrochlorothiazide)

Snippet

Sponsor: Sanofi | Conditions: Hypertension | Phase 4 | Status: COMPLETED